Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
30 Oct 2026
10 Years After Treat-to-Target Therapy in Early Rheumatoid Arthritis
Treat-to-target therapy in early rheumatoid arthritis has been associated with favourable long-term clinical, structural and functional outcomes.
Lilly’s triple action drug beats Novo's Ozempic in phase 3 trial
Lilly’s retatrutide delivered greater blood sugar reductions and more than double the weight loss of Novo’s Ozempic (semaglutide).
30 Oct 2026
Lebrikizumab Maintains Atopic Dermatitis Response for Three Years
Lebrikizumab maintained deep skin responses and sustained itch improvements for up to three years in early responders with moderate-to-severe atopic dermatitis, with infrequent flares among stable responders.
6
Mins
30 Oct 2026
We Have Misunderstood What Radiologists Do
An imaging finding does not end when the radiology report is verified; it has just started its clinical journey. The report itself informs…
30 Oct 2026
Internet Intervention Reduces Frequency of Functional Seizures
A self-guided internet-based intervention has been shown to reduce the frequency of functional seizures in adults compared with standard care.
30 Oct 2026
ECDC Review Reveals Gaps in Europe's Health Emergency Preparedness
The ECDC has found the Europe has gaps in its preparedness for global health emergencies, such as pandemics, including in workforce and data-sharing.
30 Oct 2026
Europe Adopts New AI Healthcare Roadmap
All 53 WHO European Region Member States adopted a new AI in healthcare roadmap, prioritising patient safety, governance and digital transformation.
30 Oct 2026
MASLD Survival Link in Liver Cancer Varies With BMI
A survival advantage linked to MASLD disappeared after matching, while BMI subgroup analyses suggested differing outcomes.
30 Oct 2026
MRI Metrics May Improve Early Bone Metastasis Assessment
A pilot study found that integrating diffusion-weighted MRI measures with conventional response criteria improved early classification of pelvic bone metastases in patients with lung cancer.
29 Oct 2026
Insulin Resistance Linked to Liver Fibrosis in Prediabetes
Significant liver fibrosis in prediabetes was concentrated among adults with obesity and marked insulin resistance.
←
1
2
3
4
5
…
1,641
1,642
1,643
→
We’ve noticed you’re accessing
from
North/South America.
View
View